EUVIMED · CrossrefJournal
BMJ Oncology
ISSN 2752-7948 · BMJ
Latest articles
Cross-specialty Triple M syndrome clinical practice guide: immune checkpoint inhibitor associated myasthenia-myositis-myocarditis overlap syndrome
Investigating the determinants of immunotherapy response in the primary tumour of clear cell renal cell carcinoma (RCC)
Ovarian cancer diagnosis within 28 days after an emergency admission to hospital: national population-based study of patient risk factors and cancer characteristics using routinely collected data in England
Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study
Data supply chain for cancer control and healthcare: motivation and principles
Sex differences in the cancer proteome
Rethinking global cancer guidelines
Looking inside the primary tumour: what drives immunotherapy response in renal cell carcinoma?
Operationalising digital and AI pathology in translational research and drug development: an infrastructure and regulatory perspective from biobank to companion diagnostic
VIP: validation of Italian patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE), a FICOG prospective multicentre study – results of the colorectal cancer (CRC) cohort
Trustworthy cancer data: from principles to practice
Depression and cancer survival: integrating mental healthcare into oncology practice
Foundation models in computational pathology: methods, applications and clinical implications
Temporal trends in behavioural risk factors for cancers with rising incidence in younger adults: an analysis of population-based data in England
Rethinking cancer care in conflict settings: lessons from Ukraine
Beyond stage and HPV status: the evolving landscape and future of multidisciplinary deintensification in human papillomavirus-related oropharyngeal cancer
Screen-and-treat: a sustainable solution for cervical cancer elimination in low and middle income countries
Correction for ‘Impact of loneliness on cancer mortality: a systematic review and meta-analysis’
First-in-human phase 1 dose-escalation study of W0180, an anti-VISTA monoclonal antibody, with and without pembrolizumab in patients with locally advanced or metastatic solid tumours
Unveiling the variations in penile cancer care: identifying knowledge gaps and research priorities
Communicating clinical trial information about cancer drug products to patients and healthcare professionals: review of patient-reported outcome messaging
Utilisation patterns of systemic anticancer therapy (SACT) in patients with advanced non-small cell lung cancer (NSCLC) in England
Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective
Estimating the impact of cancer diagnosis on life expectancy by stage at diagnosis: population-based estimates for a range of cancer sites in England
Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detection
CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer
Analgesic efficacy in women and men with cancer pain, treated with strong opioids: are there differences?
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials
Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice
Cost-effectiveness of neoadjuvant and adjuvant novel cancer therapies in stage II–III non-small cell lung cancer in Sri Lanka
EUVIMED